Public signalCompany raiseAuto-indexed · Unverified
Hinge Bio, Inc. raised $30.6M
Hinge Bio, Inc.· BURLINGAME, US· Biotechnology· Filed Jan 15, 2025
Hinge Bio, Inc. reported raising capital. Based in BURLINGAME, CALIFORNIA, US. First sale reported 2024-12-31. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$30.6M
Confidence90%
Raised
$30.6M
Investors
82
Jurisdiction
DELAWARE
On the record
- Location
- BURLINGAME, US
- Sector
- Biotechnology
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $30.6M
- Target amount
- $40.8M
- Filing date
- Jan 15, 2025
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Filing details
- Jurisdiction of incorporation
- DELAWARE
- Industry group
- Biotechnology
- Number of investors
- 82
- Includes non-accredited investors
- No
- Revenue range
- Decline to Disclose
- Total offering amount
- $40.8M
- Amendment
- No
People named on this filing
Officers, directors, managers and entities listed in the public filing.
Sources & provenance
“Operating company sold 30,596,388 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Jan 15, 2025. Details beyond the filing have not been verified.
Tags
USCompanyBiotechnology$10M – $100MCompany Raise
Are you associated with Hinge Bio, Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record